![]() It would be beneficial if these cases were reported more thoroughly and frequently in the future, especially by high-volume medical centers with a large body of experience. Furthermore, required radiotherapy and chemotherapy treatment should be taken into consideration. The evaluation of the patient’s comorbidities, extent of POP, age, and compliance should be mandatory. Their aim should be the optimal oncological treatment with an evaluation of the ability to achieve proper surgical treatment of POP/UI. Therefore, until more data are available, we feel that the management of these cases should be multidisciplinary, involving a urogynecologist, a gynecological oncologist, an oncological internist, and a radiologist. ![]() Only a few studies are available that address the management of patients with a gynecological malignancy complicated by POP/UI, making it difficult to make any recommendations. These patients are more likely to become long-term cancer survivors, consequently benefiting more from a combined approach to their gynecological malignancy and their POP and/or UI. More patients with endometrial and cervical cancer are diagnosed with an early-stage disease that can be cured with surgical intervention. Concurrent surgery may result in a reduction of costs of care, as well as fewer surgical complications, a shorter duration of hospitalization, and an improved quality of life. Consequently, patients with concomitant pelvic floor disorder and gynecological cancer may benefit from a simultaneous resolution of both disorders. However, as with most gynecological cancers, stress urinary incontinence and POP are treated surgically. īecause of the rarity of literature describing the management of both coexisting disorders, the best treatment approach is not clearly defined and varies greatly between different types of gynecological malignancies and different degrees of POP and UI. found that 60% of gynecological oncology patients reported at least one symptom of UI and 23% of them had severe symptoms. Almost 20% rated their symptoms as moderate to severe. In the literature, nearly two thirds of women with a gynecological malignancy reported symptoms of UI, POP, or both prior to the beginning of oncological treatment. POP/UI treatment, thought to be secondary, is therefore often delayed or completely ignored, despite being an important factor for the patient’s overall quality of life. In cases of concomitant diseases, patients are usually treated by a gynecological oncologist without a full evaluation and therapeutic intervention for their POP or UI, as the life-saving cancer surgery is the primary focus. Despite being a common condition, its coexistence with gynecological cancer is rarely reported. ![]() Roughly 13% of women undergo surgery for prolapse or urinary incontinence (UI) in their lifetime. Pelvic organ prolapse (POP) is a common condition, present to some degree in 40–60% of parous women.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |